Welcome to the e-CCO Library!

P152: Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
Year: 2021
Source: ECCO'21 Virtual
Authors: Morão, B.(1);Nascimento, C.(1);Frias Gomes, C.(1);Gonçalves, T.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P152: Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Y. Shi*, F. K. Chan, A. Higashimori, A. Chan, J. Y. Ching, J. C. Wu, J. J. Sung, S. C. Ng

Created: Friday, 22 February 2019, 9:49 AM
P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Atanassova*1, A. Georgieva2

Created: Friday, 22 February 2019, 9:41 AM
P152: Fertility and reproduction in a tertiary IBD centre: the Oxford experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

L.H. Lee1*, L. Knutzen2, J. Hollis3, R. Palmer1, S. Keshav1, S. Travis1, L. Mackillop2, O. Brain1

Created: Thursday, 21 February 2019, 9:14 AM
P152: Impact of disease location on burden of illness in patients with moderate-severe Crohn’s disease: A real-world survey in the United States, France, Germany, Italy, Spain, and United Kingdom (5EU)
Year: 2022
Source: ECCO'22
Authors: Sikirica, M.(1);Lynch, J.(2);Kershaw, J.(3);Lukanova, R.(3);Baker, S.(3);Milligan, G.(3);
Created: Friday, 11 February 2022, 3:52 PM
P152: Reconsidering the prognostic value of traditional serologic antibodies in Crohn's disease – immunoglobulin classes to take the centre stage
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sipeki N.1, Norman G.L.2, Shums Z.2, Veres G.3, Lakatos P.L.4, Antal-Szalmas P.5, Papp M.*6

Created: Wednesday, 20 February 2019, 10:36 AM
P152: The prevalence of Thiopurine-methyltransferase and NUTD15 in patient with ulcerative colitis: a hospital-based study in central Taiwan
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wu, Y.H.(1)*;Chou, J.W.(2);Po, J.H.(1);Wang, C.P.(1); Cheng, K.S.(1);
Created: Friday, 14 July 2023, 10:48 AM
P153 Fertility rate in women with IBD is decreased compared with general population: first multicentre survey in the Czech Republic
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Duricova1,2, M. Bortlik1,2,3, Z. Kratka4, L. Slaba5, T. Kovarova4, M. Lukas1, M. Pfeiferova5

Created: Thursday, 30 January 2020, 10:12 AM
P153: Association between ustekinumab trough concentrations and clinical, biochemical, and endoscopic outcomes in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Serra-Ruiz, X.(1)*;Claudia, H.D.G.(1);Mayorga Ayala, L.(1);Robles Alonso, V.(1);Céspedes Martínez, E.(1);Casellas, F.(1);Miarons, M.(2);Garcia-Garcia, S.(2);Pérez Martínez, Z.(1);Oller, E.(1);Borruel Sainz, N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P153: IBD patients’ treatment preferences are heterogeneous, but largely affected by the avoidance of abdominal pain and side effects (P-POWER IBD study)
Year: 2021
Source: ECCO'21 Virtual
Authors: Louis, E.(1);Siegel, C.A.(2);James, B.(3);Heidenreich, S.(4);Krucien, N.(4);Ghosh, S.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P153: Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Ricken1, M. Schneider*1, F. Bantleon1, S. Velayutham1, D. Trapani1, J. Afonso2, F. Magro2, A. Abel1

Created: Friday, 22 February 2019, 9:41 AM
P153: Role of 3D endoanal ultrasound in perianal fistulising Crohns's disease. Preliminary results
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Luglio G.*1, Giglio M.C.2, Rispo A.2, Imperatore N.3, Sollazzo V.2, Peltrini R.2, Sacco M.2, Castiglione F.4, De Palma G.D.2, Bucci L.2

Created: Wednesday, 20 February 2019, 10:36 AM
P153: The air-enema image of ultra-low-dose CT colonography can be an alternative diagnostic technique for the assessment of mucosal healing in the patients with ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

K. Takeuchi*, A. Yamada, Y. Suzuki

Created: Thursday, 21 February 2019, 9:14 AM
P153: The impact of seton use on clinical and patient-reported outcomes in Crohn’s disease perianal fistulas: findings from a systematic literature review
Year: 2022
Source: ECCO'22
Authors: White, I.(1);Karki, C.(2);Geransar , P.(3);Worsfold, A.(4);Leisle, L.(5);Junker, S.(5);Fleshner, P.(6);
Created: Friday, 11 February 2022, 3:52 PM
P153: Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registry
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

L. Wauters*1, F. Smets2, E. De Greef3, P. Bontems4, I. Hoffman5, B. Hauser3, P. Alliet6, W. Arts7, H. Peeters8, S. Van Biervliet9, I. Paquot10, E. Van de Vijver11, M. De Vos12, P. Bossuyt13, J.-F. Rahier14, O. Dewit15, T. Moreels15, D. Franchimont16, V. Muls16, F. Fontaine17, E. Louis17, J.-C. Coche18, J. Paul19, F. Baert20, S. Vermeire1, G. Veereman3

Created: Friday, 22 February 2019, 9:49 AM
P154 Sinusitis Prompts Evaluation for Co-existing or Subsequent inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

V. Rai, C. Traboulsi, G. Gulotta, D. Rubin

Created: Thursday, 30 January 2020, 10:12 AM
P154: A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent inception cohorts
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Bazov, I.(1);Kruse, R.(2);Bergemalm, D.(3);Eriksson, C.(3);Hedin, C.R.(4,5);Carlson, M.(6);van Nieuwenhoven, M.(3);Keita, Å.V.(7);Magnusson, M.K.(8);Almer, S.(4,9);Strid, H.(10);Bache-Wiig Mathisen, C.(11,12);Bengtsson, M.B.(13);Bergene Aabrekk, T.(12,13);Medhus, A.W.(11,12);Detlie, T.E.(14,15);Frigstad, S.O.(16);Huppertz-Hauss, G.(17);Opheim, R.(11,18);Ricanek, P.(14,19);Kristensen, V.A.(11,20);Salihovic, S.(21);D'Amato, M.(22,23); Öhman, L.(8);Söderholm, J.D.(7);Lindqvist, C.M.(24);Repsilber, D.(1);HøivikMD- PhD, M.L.(11,12);Halfvarson, J.(3)*;
Created: Friday, 14 July 2023, 10:48 AM
P154: Clinical assessment of prognosis and the prognostic factors in intestinal Bahcet’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Hachiya*, T. Sakurai, Y. Nagata, A. Hidaka, Y. Akita, H. Miyashita, Y. Maruyama, R. Miyazaki, M. Noguchi, R. Sawada, J. Mitobe, M. Mitsunaga, T. Yamasaki, T. Kato, M. Saruta

Created: Thursday, 21 February 2019, 9:14 AM
P154: Complete sequence-based NUDT15 and TPMT variants for predicting thiopurine-induced leukopenia in patients with Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kim T.J., Kim E.R., Hong S.N., Chang D.K., Kim Y.-H.

Created: Wednesday, 20 February 2019, 10:36 AM
P154: Development of a novel ultrasound based score for assessing disease activity in ulcerative colitis: preliminary results
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

P. Kakkadasam Ramaswamy*1, A. Yelsangikar1, K. V. Nagarajan1, A. Nagar1, N. Bhat1

Created: Friday, 22 February 2019, 9:41 AM